Today's Daily Dose brings you an update on Agile's corporate business, news on promising results of AmpliPhi's investigational bacteriophage therapeutic AB-SA01; BioMarin's receipt of milestone payments related to breast cancer drug candidate Talazoparib and FDA clearance of EDAP's Focal One device.